Establishing the bidirectional relationship between depression and subclinical arteriosclerosis - rationale, design, and characteristics of the BiDirect Study

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Teismann, Henning ^a   Wersching, Heike ^a   Nagel, Maren ^a   Arolt, Volker ^a   Heindel, Walter ^a   Baune, Bernhard T ^b   Wellmann, Jürgen ^a   Hense, Hans Werner ^a   Berger, Klaus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

(f)MRI; Arteriosclerosis; Bidirectional; Cardiovascular; Cerebrovascular; Depression; Depression subtypes; Prospective cohort study; White matter hyperintensities

Indexed keywords

DNA;

ACUTE DISEASE; ADULT; AGED; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTICLE; ATYPICAL DEPRESSION; BEHAVIOR CHANGE; BLOOD PRESSURE; BLOOD SAMPLING; BODY IMPEDANCE; COGNITION; CONTROLLED STUDY; DEPRESSION; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EMOTION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HEART DISEASE; HIGH RISK BEHAVIOR; HUMAN; IMPEDANCE; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; PAIN; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SMELLING; VISUAL ACUITY; ASYMPTOMATIC DISEASES; BRAIN; COMORBIDITY; DEPRESSIVE DISORDER;

ADULT; AGED; ARTERIOSCLEROSIS; ASYMPTOMATIC DISEASES; BRAIN; CAROTID INTIMA-MEDIA THICKNESS; COMORBIDITY; DEPRESSIVE DISORDER; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 84902053766     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-174     Document Type: Article

References (41)

1. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J 2014, 35(21):1365-1372. 10.1093/eurheartj/eht462, 24282187.
2. Mathers C, Fat D, Boerma J. The Global Burden of Disease: 2004 Update 2008, Geneva: World Health Organization.
3. Baumeister H, Parker G. Meta-review of depressive subtyping models. J Affect Disord 2012, 139:126-140. 10.1016/j.jad.2011.07.015, 21885128.
4. Baune BT, Stuart M, Gilmour A, Wersching H, Arolt V, Berger K. Moderators of the relationship between depression and cardiovascular disorders: a systematic review. Gen Hosp Psychiatry 2012, 34:478-492. 10.1016/j.genhosppsych.2012.05.013, 22771109.
5. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325. 10.1038/nature10146, 21593864.
6. Burnett JR. Lipids, lipoproteins, atherosclerosis and cardiovascular disease. Clin Biochem Rev 2004, 25:2. 1853363, 18516207.
7. Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 2008, 79:619-624.
8. Davidson KW, Rieckmann N, Rapp MA. Definitions and distinctions among depressive syndromes and symptoms: implications for a better understanding of the depression-cardiovascular disease association. Psychosom Med 2005, 67(Suppl 1):S6-S9.
9. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996, 93:1976-1980. 10.1161/01.CIR.93.11.1976, 8640971.
10. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774. 10.1093/eurheartj/ehl338, 17082208.
11. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003, 54:241-247. 10.1016/S0006-3223(03)00111-2, 12893100.
12. Baune BT, Stuart M, Gilmour A, Wersching H, Heindel W, Arolt V, Berger K. The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl Psychiatry 2012, 2:e92. 10.1038/tp.2012.18, 3309537, 22832857.
13. Ye S, Muntner P, Shimbo D, Judd SE, Richman J, Davidson KW, Safford MM. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol 2013, 61:622-630. 10.1016/j.jacc.2012.09.058, 3568239, 23290548.
14. Win S, Parakh K, Eze-Nliam CM, Gottdiener JS, Kop WJ, Ziegelstein RC. Depressive symptoms, physical inactivity and risk of cardiovascular mortality in older adults: the cardiovascular health study. Heart 2011, 97:500-505. 10.1136/hrt.2010.209767, 3044493, 21339320.
15. Blumenthal JA. Targeting lifestyle change in patients with depression. J Am Coll Cardiol 2013, 61:631-634. 10.1016/j.jacc.2012.11.029, 3755499, 23290546.
16. Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis 2013, 55:511-523. 10.1016/j.pcad.2013.03.010, 23621961.
17. Gasse C, Laursen TM, Baune BT. Major depression and first-time hospitalization with ischemic heart disease, cardiac procedures and mortality in the general population: a retrospective Danish population-based cohort study. Eur J Prev Cardiol 2014, 21(5):532-540. 10.1177/2047487312467874, 23155197.
18. Wersching H, Berger K. New cohorts. The BiDirect study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012, 55:822-823. 10.1007/s00103-012-1491-6, 22736162.
19. Ackenheil M, Stotz-Ingenlath G, Dietz-Bauer R, Vossen A. M.I.N.I. Mini International Neuropsychiatric Interview (German version 5.0.0, DSM-IV) 1999, Munich: Psychiatric University Clinic.
20. Rush A, Giles D, Schlesser M. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res 1986, 18:65-87. 10.1016/0165-1781(86)90060-0, 3737788.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
22. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55. 10.1111/j.2044-8341.1959.tb00467.x, 13638508.
23. Wellmann J, Heidrich J, Berger K, Döring A, Heuschmann PU, Keil U. Changes in alcohol intake and risk of coronary heart disease and all-cause mortality in the MONICA/KORA-Augsburg cohort 1987-97. Eur J Cardiovasc Prev Rehabil 2004, 11:48-55. 10.1097/01.hjr.0000118174.70522.20, 15167206.
24. Berger K. DHS: the Dortmund health study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012, 55:816-821. 10.1007/s00103-012-1492-5, 22736161.
25. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213. 10.1016/0165-1781(89)90047-4, 2748771.
26. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
27. Pfaffenrath V, Fendrich K, Vennemann M, Meisinger C, Ladwig K-H, Evers S, Straube A, Hoffmann W, Berger K. Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia 2009, 29:48-57. 10.1111/j.1468-2982.2008.01699.x, 18771491.
28. Ruscheweyh R, Verneuer B, Dany K, Marziniak M, Wolowski A, Colak-Ekici R, Schulte TL, Bullmann V, Grewe S, Gralow I, Evers S, Knecht S. Validation of the pain sensitivity questionnaire in chronic pain patients. Pain 2012, 153:1210-1218. 10.1016/j.pain.2012.02.025, 22541722.
29. Grabe HJ, Schulz A, Schmidt CO, Appel K, Driessen M, Wingenfeld K. Childhood Trauma Screener (CTS) - a brief instrument for the assessment of childhood abuse and neglect. Psychiatr Prax 2012, 39:109-115.
30. Prochaska J, Velicer W. The transtheoretical model of health behavior change. Am J Heal Promot 1997, 12:38-48.
31. Rabin R, De Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001, 33:337-343. 10.3109/07853890109002087, 11491192.
32. Kissler J, Assadollahi R, Herbert C. Emotional and semantic networks in visual word processing: insights from ERP studies. Prog Brain Res 2006, 156:147-183.
33. Aschenbrenner S, Tucha O, Lange K. Regensburger Wortflüssigkeits-Test 2000, Göttingen Bonn Toronto Seattle: Hogrefe.
34. Oswald W, Fleischmann U. Nürnberger-Alters-Inventar 1997, Göttingen Bonn Toronto Seattle: Hogrefe.
35. Reitan R. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958, 8:271-276.
36. Tiffin J, Asher E. The Purdue pegboard: norms and studies of reliability and validity. J Appl Psychol 1948, 32:234-247.
37. Dannlowski U, Ohrmann P, Konrad C, Domschke K, Bauer J, Kugel H, Hohoff C, Schöning S, Kersting A, Baune BT, Mortensen LS, Arolt V, Zwitserlood P, Deckert J, Heindel W, Suslow T. Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol 2009, 12:11-22. 10.1017/S1461145708008973, 18544183.
38. Debette S, Markus H. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010, 341:c3666. 10.1136/bmj.c3666, 2910261, 20660506.
39. Kuller LH, Arnold AM, Longstreth WT, Manolio TA, O'Leary DH, Burke GL, Fried LP, Newman AB. White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol Aging 2007, 28:1307-1315. 10.1016/j.neurobiolaging.2006.06.010, 16857296.
40. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging 2009, 30:946-956. 10.1016/j.neurobiolaging.2007.08.023, 17950492.
41. Sundermann B, Herr D, Schwindt W, Pfleiderer B. Multivariate classification of blood oxygen level-dependent fMRI data with diagnostic intention: a clinical perspective. AJNR Am J Neuroradiol 2014, 35(5):848-855. 10.3174/ajnr.A3713, 24029388.